We examined the biologic tumor behavior in Helicobacter pylori-seropositive patients with gastric adenocarcinoma. A total of 214 consecutive patients with pathologically confirmed adenocarcinoma of the stomach who underwent gastric resection were studied. The stored serum samples were tested for serum antibody to H. pylori by using a highly sensitive and specific IgG enzyme-linked immunosorbent assay. The difference in H. pylori-seropositive and seronegative patients with gastric adenocarcinoma was evaluated in terms of various clinicopathologic parameters. A multivariate logistic regression analysis was used to adjust for potential confounding variables. Antibodies to H. pylori were detected in 65.9% of patients with gastric adenocarcinoma. H. pylori-seropositive patients were younger than seronegative patients and had infiltrative tumor according to Ming's criteria. When adjusted for age, infiltrative tumor come out stronger. These findings suggest that H. pylori infection may be related to infiltrative type gastric adenocarcinoma; further study is necessary.
BurukF., BerberogluU., ParkI., AksazE., CelenO.: Gastric cancer and Helicobacter pylori infection.Br. J. Surg., 80: 378–379, 1993.
2.
CarusoM.L., FucciL.: Histological identification of Helicobacter pylori in early and advanced gastric cancer.J. Clin. Gastroenterol., 12: 601–602, 1990.
3.
CorreaP., RuizB.: Campylobacter pylori and gastric cancer. In: Campylobacter pylori and gastroduodenal disease, RathboneB.J., HeatlyR.V. (Eds.), Blackwell Scientific, Oxford, pp. 139–145, 1989.
4.
CorreaP.: Is gastric carcinoma an infectious disease? N.Engl. J. Med., 325: 1170–1171, 1991.
5.
Department of Health.A report on Morbidity Survey in Public and Private Hospitals and Clinics, Taiwan area, R.O.C. p. 297, 1989.
6.
DixonW.J.: BMDP statistical software.Berkeley: University of California Press, pp. 143–594, 1985.
7.
DooleyC.P., CohenH.: The clinical significance of Campylobacter pylori.Ann. Intern. Med., 108: 70–79, 1988.
8.
FormanD., SitasF., NewellD.G., StaceyA.R., BorehamJ., PetoR., CampbellT.C., LiJ., ChenJ.: Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China.Int. J. Cancer, 46: 608–611, 1990.
9.
GoodwinC.S., BlincowE., PetersonG., SandersonC., ChengW., MarshallB., WarrenJ.R., McCullochR.: Enzyme-linked immunosorbent assay for Campylobacter pyloridis: correlation with presence of C. pyloridis in the gastric mucosa.J. Infect. Dis., 155: 488–494, 1987.
10.
HowsonC.P., HiyamaT., WynderE.L.: The decline in gastric cancer: epidemiology of an unplanned triumph.Epidemiol. Rev., 8: 1–27, 1986.
11.
Identification system for Campylobacter. Instruction manual.Amrad Corp. Ltd., Lyon, France, 1991.
12.
Japanese Research Society for Gastric Cancer: The general rules for the gastric cancer study in surgery and pathology.Jpn. J. Surg., 11: 127–145, 1981.
13.
LaurenP.: The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. An attempt at a histoclinical classification.Acta Pathol. Microbiol. Scand., 64: 31–49, 1965.
14.
LinJ.T., WangJ.T., WangT.H., WuM.S., LeeT.K., ChenC.J.: Helicobacter pylori infection in a randomly selected population, healthy volunteers, and patients with gastric ulcer and gastric adenocarcinoma. A seroprevalence study in Taiwan.Scand. J. Gastroenterol., 28: 1067–1072, 1993.
MingS.C.: Gastric carcinoma: A pathological classification.Cancer, 39: 2475–2485, 1977.
17.
MorganD.R., LeunkR.D.: Pathogenesis of infection by C. pylori. In: Campylobacter pylori in gastritis and peptic ulcer disease,BlaserM.J. (Ed.), pp. 115–133, Igaku-Shoin, New York, 1989.
18.
MorrisA.J., AliM.R., NicholsonG.I., Perez-PerezG.I., BlaserM.J.: Long-term follow-up of voluntary ingestion of Helicobacter pylori. Ann.Intern. Med., 114: 662–663, 1991.
19.
MunozN., CorreaP., CuelloC., DuqueE.: Histologic types of gastric cancer in high- and low-risk areas.Int. J. Cancer, 3: 809–818, 1968.
20.
NomuraA., StemmermannG.N., ChyouP.H., KatoI., Perez-PerezG.I., BlaserM.J.: Helicobacter pylori infection and gastric carcinoma among Japanese- Americans in Hawaii.N. Engl. J. Med., 325: 1132–1136, 1991.
21.
ParkinD.M., LarraE., MuirC.S.: Estimates of the worldwide frequency of sixteen major cancers in 1980. Int.J. Cancer, 41: 184–197, 1988.
22.
ParsonnetJ., FriedmanG.D., VandersteenD.P., ChangY., VogelmanJ.H., OrentreichN., SibleyR.K.: Helicobacter pylori infection and the risk of gastric carcinoma.N. Engl. J. Med., 325: 1127–1131, 1991.
23.
ParsonnetJ., VandersteenD., GoatesJ., SibleyR.K., PritikinJ., ChangY.: Helicobacter pylori in intestinal- and diffuse-type gastric adenocarcinomas.J. Natl. Cancer Inst., 83: 640–643, 1991.
ScottN., LansdownM., DiamentR., McMahonM., LansdownM., RathboneB., WyattJ.I., DixonM.F., QuirkeP.: Helicobater gastritis and intestinal metaplasia in a gastric cancer family.Lancet, 335: 728, 1990.
26.
SipponenP., JarviO., KekkiM., SiuralaM.: Decreased incidences of intestinal and diffuse types of gastric cancer in Finland during a 20-year period.Scand. J. Gastroenterol., 22: 865–871, 1987.
27.
SipponenP., KosunenT.U., ValleJ., RiihelaM., SeppalaK.: Helicobacter pylori infection and chronic gastritis in gastric cancer.J. Clin. Pathol., 45: 319–323, 1992.
28.
TalleyN.J., ZinsmeisterA.R., WeaverA., DiMagnoE.P., CarpenterH.A., Perez-PerezG.I., BlaserM.J.: Gastric adenocarcinoma and Helicobacter pylori infection.J. Natl. Cancer Inst., 83: 1734–1739, 1991.
29.
YangP.C., DavisS.: Epidemiological characteristics of the gastric cardia and distal stomach in the United States, 1973-82. Int.J. Epidemiol., 17: 293–297, 1988.
